Use of programmed cell death protein ligand 1 assay to predict the outcomes of non-small cell lung cancer patients treated with immune checkpoint inhibitors

Checkpoint Inhibitors ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Cell Death Protein

Relationship between Programmed Cell Death Protein Ligand 1 Expression and Immune-related Adverse Events in Non-small-cell Lung Cancer Patients Treated with Pembrolizumab

JMA Journal ◽

10.31662/jmaj.2019-0005 ◽

2019 ◽

Keyword(s):

Lung Cancer ◽

Cell Death ◽

Programmed Cell Death ◽

Adverse Events ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Cell Death Protein

Re: Comments on ‘High-intensity statins are associated with improved clinical activity of programmed cell death protein 1 inhibitors in malignant pleural mesothelioma and advanced non–small cell lung cancer patients’

European Journal of Cancer ◽

10.1016/j.ejca.2021.05.016 ◽

2021 ◽

Author(s):

Luca Cantini ◽

Federica Pecci ◽

Floris Dammeijer ◽

Joachim G.J.V. Aerts ◽

Rossana Berardi

Keyword(s):

Lung Cancer ◽

Cell Death ◽

Programmed Cell Death ◽

Cancer Patients ◽

Small Cell ◽

Clinical Activity ◽

Pleural Mesothelioma ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Cell Death Protein

Prognostic impact of primary cancer adjoining emphysematous bullae in non-small cell lung cancer patients treated with immune checkpoint inhibitors

Cancer Immunology Immunotherapy ◽

10.1007/s00262-020-02783-6 ◽

2021 ◽

Author(s):

Shinkichi Takamori ◽

Kazuki Takada ◽

Mototsugu Shimokawa ◽

Mikako Jinnnouchi ◽

Taichi Matsubara ◽

...

Keyword(s):

Lung Cancer ◽

Cancer Patients ◽

Immune Checkpoint ◽

Checkpoint Inhibitors ◽

Small Cell ◽

Prognostic Impact ◽

Primary Cancer ◽

Small Cell Lung ◽

Blood tumor mutation burden can predict the clinical response to immune checkpoint inhibitors in advanced non-small cell lung cancer patients

Cancer Immunology Immunotherapy ◽

10.1007/s00262-021-02943-2 ◽

2021 ◽

Author(s):

Xi Chen ◽

Liangjie Fang ◽

Yanping Zhu ◽

Zhang Bao ◽

Qing Wang ◽

...

Keyword(s):

Lung Cancer ◽

Cancer Patients ◽

Immune Checkpoint ◽

Checkpoint Inhibitors ◽

Small Cell ◽

Small Cell Lung ◽

Tumor Mutation Burden ◽

Lung Cancer Patients ◽

Mutation Burden

Predictive Value of Combining Biomarkers for Clinical Outcomes in Advanced Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors

Clinical Lung Cancer ◽

10.1016/j.cllc.2021.03.017 ◽

2021 ◽

Author(s):

Chester Kao ◽

Eric Powers ◽

Yuan Wu ◽

Michael B. Datto ◽

Michelle F. Green ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Immune Checkpoint ◽

Predictive Value ◽

Checkpoint Inhibitors ◽

Small Cell ◽

Small Cell Lung ◽

Clinical Efficacy of Immune Checkpoint Inhibitors in Older Non-small-Cell Lung Cancer Patients: A Meta-Analysis

Frontiers in Oncology ◽

10.3389/fonc.2020.558454 ◽

2020 ◽

Vol 10 ◽

Author(s):

You-Meng Sun ◽

Ying Wang ◽

Xin-Xing Sun ◽

Jing Chen ◽

Zhi-Ping Gong ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Immune Checkpoint ◽

Checkpoint Inhibitors ◽

Meta Analysis ◽

Small Cell ◽

Small Cell Lung ◽

Immune Checkpoint Inhibitors Rechallenge Efficacy in Non–Small-Cell Lung Cancer Patients

Clinical Lung Cancer ◽

10.1016/j.cllc.2020.04.013 ◽

2020 ◽

Vol 21 (5) ◽

pp. e497-e510 ◽

Cited By ~ 2

Author(s):

Elisa Gobbini ◽

Anne Claire Toffart ◽

Maurice Pérol ◽

Jean-Baptiste Assié ◽

Michaël Duruisseaux ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Immune Checkpoint ◽

Checkpoint Inhibitors ◽

Small Cell ◽

Small Cell Lung ◽

PROGRAMMED CELL DEATH-LIGAND 1 EXPRESSION AND IMMUNOSCORE IN STAGE II AND III NON-SMALL CELL LUNG CANCER PATIENTS RECEIVING ADJUVANT CHEMOTHERAPY

Respirology ◽

10.1111/resp.13207_73 ◽

2017 ◽

Vol 22 ◽

pp. 113-113

Keyword(s):

Lung Cancer ◽

Cell Death ◽

Adjuvant Chemotherapy ◽

Programmed Cell Death ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

Sarcopenia affects clinical efficacy of immune checkpoint inhibitors in non-small cell lung cancer patients: A systematic review and meta-analysis

International Immunopharmacology ◽

10.1016/j.intimp.2020.106907 ◽

2020 ◽

Vol 88 ◽

pp. 106907 ◽

Cited By ~ 1

Author(s):

Jiajun Wang ◽

Liu Cao ◽

Shun Xu

Keyword(s):

Lung Cancer ◽

Systematic Review ◽

Cancer Patients ◽

Immune Checkpoint ◽

Checkpoint Inhibitors ◽

Meta Analysis ◽

Small Cell ◽

Small Cell Lung ◽

Dissociated responses at initial computed tomography evaluation is a good prognostic factor in non-small cell lung cancer patients treated with anti-programmed cell death-1/ligand 1 inhibitors

BMC Cancer ◽

10.1186/s12885-020-6704-z ◽

2020 ◽

Vol 20 (1) ◽

Cited By ~ 1

Author(s):

Takehiro Tozuka ◽

Satoru Kitazono ◽

Hiroaki Sakamoto ◽

Hiroshi Yoshida ◽

Yoshiaki Amino ◽

...

Keyword(s):

Computed Tomography ◽

Lung Cancer ◽

Cell Death ◽

Prognostic Factor ◽

Programmed Cell Death ◽

Cancer Patients ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Programmed Cell Death 1